HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES CLINICAL DEVELOPMENT/COMMERCIALIZATION AGREEMENT WITH SCHERING-PLOUGH K.K.
-
PR Newswire; Jan 27, 1993; 700+ Words
...SciClone Pharmaceuticals. "As we...invaluable to SciClone." Hepatitis...marketing of pharmaceutical and health...worldwide. SciClone Pharmaceuticals, Inc...and CEO of SciClone Pharmaceuticals...
-
-
SciClone Pharmaceuticals Announces European Patent Office Grants Patent for Use of Thymosin Alpha 1 as a Treatment for Hepatitis C
-
PR Newswire; Sep 11, 1997; 700+ Words
...collaborations with major pharmaceutical companies in the U...tremendous importance to SciClone as we move forward." SciClone Pharmaceuticals, Inc. is an international...pharmaceuticals worldwide. SciClone focuses on specialist...
-
-
SciClone Pharmaceuticals Announces 1996 Third Quarter Financial Results
-
PR Newswire; Oct 18, 1996; 700+ Words
...PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq...767 SOURCE SciClone Pharmaceuticals Inc. -0- 10/18...site. For a menu of SciClone press releases or...Financial Officer of SciClone Pharmaceuticals...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES EXCLUSIVE LICENSING AGREEMENT FOR THYMOSIN ALPHA 1
-
PR Newswire; Aug 22, 1994; 700+ Words
...Aug. 22 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN), today...Biomedicals, Inc., which gives SciClone additional worldwide rights to...Alpha 1. The agreement gives SciClone exclusive marketing rights to...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES FIRST QUARTER 1994 FINANCIAL RESULTS; 4TH QUARTER ZADAXIN(TM) SHIPMENTS ANTICIPATED
-
PR Newswire; Apr 22, 1994; 700+ Words
...PRNewswire/ -- SciClone Pharmaceuticals Inc. (NASDAQ: SCLN...Mark A. Culhane, SciClone's Director of Finance...finance of SciClone Pharmaceuticals, 415-358-3456/ (SCLN) CO: SciClone Pharmaceuticals Inc...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES APPROVAL TO BEGIN CLINICAL TRIALS IN JAPAN FOR THYMOSIN ALPHA 1
-
PR Newswire; Jul 7, 1993; 688 Words
...July 6 /PRNewswire/ -- SciClone Pharmaceuticals Inc. (NASDAQ: SCLN) today...Schering-Plough Corp. and SciClone Pharmaceuticals Inc. announced...Japan. In return, SPKK will pay SciClone initial and milestone payments...
-
-
SciClone Pharmaceuticals Announces Record Revenues for the Second Quarter Of 2000.
-
PR Newswire; Jul 17, 2000; 700+ Words
...of the world's largest pharmaceutical markets and the 20th international...Trademark Office granted SciClone a U.S. patent covering...disease among Caucasians. -- SciClone presented at the UBS Warburg Global Specialty Pharmaceuticals Conference (New York...Francisco). ZADAXIN, SciClone's ...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES 1995 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
-
PR Newswire; Jan 19, 1996; 700+ Words
...Jan. 19 /PRNewswire/ -- SciClone Pharmaceuticals, Inc., (Nasdaq: SCLN) today...stated Mark A. Culhane, SciClone's Chief Financial Officer...trials," he added. ZADAXIN, SciClone's lead product, is being investigated...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES 1993 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
-
PR Newswire; Jan 20, 1994; 700+ Words
...Jan. 20 /PRNewswire/ -- SciClone Pharmaceuticals, Inc., (NASDAQ: SCLN...drug," said Thomas E. Moore, SciClone's Chairman and CEO. "Furthermore, as previously announced, SciClone has filed for marketing approval...
-
-
SciClone Pharmaceuticals Announces Positive Preliminary Data From Phase 3 Hepatitis B Trial in Japan.
-
PR Newswire; Mar 5, 2002; 700+ Words
...and certain cancers. SciClone develops and commercializes pharmaceutical and biological therapeutic...acquired or in-licensed. SciClone's goal, based on the...corporate information from SciClone Pharmaceuticals are available on the...
-
-
SciClone Pharmaceuticals Announces 1997 First Quarter Financial Results
-
PR Newswire; Apr 28, 1997; 700+ Words
...create a strong position for SciClone in those major developing...interest from several major pharmaceutical companies regarding the...achieved by the Company. SciClone Pharmaceuticals is an international biopharmaceutical...pharmaceuticals worldwide. SciClone focuses on specialist...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES SECOND QUARTER 1995 FINANCIAL RESULTS
-
PR Newswire; Jul 20, 1995; 700+ Words
...July 20 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) today...stated Mark A. Culhane, SciClone's chief financial officer...requesting access to ZADAXIN." SciClone is an international biopharmaceutical...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES THIRD QUARTER 1995 FINANCIAL RESULTS
-
PR Newswire; Oct 19, 1995; 700+ Words
...Oct. 19 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) today...corresponding period in 1994. SciClone is an international biopharmaceutical...and immune system disorders. SCICLONE PHARMACEUTICALS, INC. CONSOLIDATED...
-
-
SciClone Pharmaceuticals Announces 1997 Second Quarter Financial Results
-
PR Newswire; Jul 28, 1997; 700+ Words
...PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq...Executive Officer of SciClone. "We believe these...with several major pharmaceutical companies in the...by the Company. SciClone Pharmaceuticals, Inc. is an international...pharmaceuticals worldwide. SciClone ...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES SECOND QUARTER 1994 FINANCIAL RESULTS
-
PR Newswire; Jul 21, 1994; 700+ Words
...July 21 /PRNewswire/ -- SciClone Pharmaceuticals Inc. (Nasdaq: SCLN) today...said Mark A. Culhane, SciClone's chief financial officer...the second quarter levels." SciClone closed the quarter with approximately...
-
-
SciClone Pharmaceuticals Announces Successful Reformulation of CPX For Expanded Phase 2 Studies in Cystic Fibrosis Patients.
-
PR Newswire; Nov 10, 2000; 700+ Words
...Nov. 10 /PRNewswire/ -- SciClone Pharmaceuticals (Nasdaq: SCLN) today announced...environment of the CF patient. SciClone said it plans to initiate expanded...CFF, which already has granted SciClone over $500,000 for the development...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES THIRD QUARTER 1994 FINANCIAL RESULTS
-
PR Newswire; Oct 20, 1994; 700+ Words
...Oct. 20 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) today...stated Mark A. Culhane, SciClone's Chief Financial Officer...million in cash and investments." SciClone Pharmaceuticals, Inc. is engaged...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES FIRST QUARTER 1995 FINANCIAL RESULTS
-
PR Newswire; Apr 20, 1995; 700+ Words
...April 20 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) today...stated Mark A. Culhane, SciClone's Chief Financial Officer...million in cash and investments." SciClone Pharmaceuticals, Inc. is an...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES 1994 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
-
PR Newswire; Jan 27, 1995; 700+ Words
...Jan. 27 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) today...stated Mark A. Culhane, SciClone's Chief Financial Officer...million in cash and investments." SciClone Pharmaceuticals, Inc., is...
-
-
SCICLONE PHARMACEUTICALS ANNOUNCES PLAN TO FILE FOR REGULATORY APPROVAL OF ZADAXIN(R) THYMOSIN ALPHA 1 IN TAIWAN AS A TREATMENT FOR CHRONIC HEPATITIS B
-
PR Newswire; Jul 31, 1996; 700+ Words
...PRNewswire/ -- SciClone Pharmaceuticals, Inc. (Nasdaq...an independent pharmaceutical research consulting...hepatitis B trial to SciClone is that a sufficient...Executive Officer of SciClone Pharmaceuticals. Taiwan Results...
|
|